The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1175, doi. 10.1007/s00262-008-0652-9
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2009 AND VI 58 AND IP 8
Results: 17
1
2
Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1319, doi. 10.1007/s00262-008-0647-6
- By:
- Publication type:
- Article
3
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1297, doi. 10.1007/s00262-008-0642-y
- By:
- Publication type:
- Article
4
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1307, doi. 10.1007/s00262-008-0644-9
- By:
- Publication type:
- Article
5
Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1275, doi. 10.1007/s00262-008-0645-8
- By:
- Publication type:
- Article
6
Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1257, doi. 10.1007/s00262-008-0638-7
- By:
- Publication type:
- Article
7
Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1265, doi. 10.1007/s00262-008-0640-0
- By:
- Publication type:
- Article
8
Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1287, doi. 10.1007/s00262-008-0641-z
- By:
- Publication type:
- Article
9
A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1245, doi. 10.1007/s00262-008-0643-x
- By:
- Publication type:
- Article
10
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1329, doi. 10.1007/s00262-008-0648-5
- By:
- Publication type:
- Article
11
Breast cancer cells expressing stem cell markers CD44<sup>+</sup> CD24<sup>lo</sup> are eliminated by Numb-1 peptide-activated T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1185, doi. 10.1007/s00262-008-0623-1
- By:
- Publication type:
- Article
12
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi- scid, IL-2Rγ<sup>null</sup> mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1195, doi. 10.1007/s00262-008-0632-0
- By:
- Publication type:
- Article
13
Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma.
- Published in:
- 2009
- By:
- Publication type:
- Letter
14
TGF-alpha as a candidate tumor antigen for renal cell carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1207, doi. 10.1007/s00262-008-0630-2
- By:
- Publication type:
- Article
15
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1219, doi. 10.1007/s00262-008-0628-9
- By:
- Publication type:
- Article
16
A cell-based high-throughput screen to identify synergistic TRAIL sensitizers.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1229, doi. 10.1007/s00262-008-0637-8
- By:
- Publication type:
- Article
17
Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1337, doi. 10.1007/s00262-009-0659-x
- By:
- Publication type:
- Article